Netherlands· NL-32ee0833b4a2
Rizatriptan Sandoz 5 mg, orodispergeerbare tabletten
A rizatriptan product containing rizatriptanbenzoaat, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Rizatriptan is registered in 16 of 19 countries.
Countries holding a registration under ATC N02CC04 (rizatriptan), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Rizatriptan · ATC N02CC04
16 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of rizatriptan costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $1.25 in France to $10.95 in Switzerland — a ×8.8 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rizatriptan · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$10.95
- ES Spain$5.01
- IT Italy$2.91
- FR France$1.25
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- RIZATRIPTANBENZOAAT
- Manufacturer
- Sandoz B.V.
- Country
- Netherlands (NL)
- ATC code
- N02CC04
- ATC class
- Rizatriptan
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id101957
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
106 interactions on record for rizatriptan.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rizatriptan · interactions on record
106 records
- 11 severe
- 6 moderate
- 88 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rizatriptan in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMaxalt 10mg tabletsCST Pharma Ltd
- SpainMAXALT 10 mg COMPRIMIDOSOrganon Salud S.L.
- CanadaACCEL-RIZATRIPTAN ODTACCEL PHARMA INC
- ItalyEMIRIZIANEURAXPHARM ITALY S.P.A.
- SwitzerlandMaxalt 10 mg, TablettenOrganon GmbH
- SwedenRizasmelt 10 mg Munsönderfallande tablettSTADA Arzneimittel AG
- FranceMAXALT 10 mg, compriméORGANON FRANCE
- Japanリザトリプタン安息香酸塩オルガノン
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Germany · Rizatriptan Al, Rizatriptan Glenmark
- Denmark · Rizasmelt, Rizatriptan ”stada”
- Spain · Rizatriptán Flas Kern Pharma, Rizatriptán Max Viatris
- Finland · Rizastad, Rizatriptan Stada
- France · Rizatriptan Eg, Rizatriptan Viatris
- United Kingdom (Northern Ireland) · Rizatriptan Glenmark Pharmaceuticals Europe, Rizatriptan Macleods Pharma Uk
- Croatia · Emalt
- Italy · Rizatriptan Mylan Generics, Rizatriptan Sandoz
- Sweden · Rizasmelt, Rizatriptan Glenmark
- Slovakia · Rizatriptan Sandoz, Rizatriptan Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd68de22-98c7-423d-ba93-c8f6ec3eea29 GET /v1/drugs/cd68de22-98c7-423d-ba93-c8f6ec3eea29?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Orodispergeerbare tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h101957_smpc.pdf",
"strength": null,
"atc_label": "Rizatriptan",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg101957",
"excipients": [
"ARABISCHE GOM (E 414)",
"ASCORBINEZUUR (E 300)",
"ASPARTAAM (E 951)",
"CALCIUMSILICAAT (E 552)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSPOVIDON (E 1202)",
"ETHYLBUTYRAAT",
"MAGNESIUMSTEARAAT (E 470b)",
"MALTODEXTRINE",
"MANNITOL (D-) (E 421)",
"SILICIUMDIOXIDE (E 551)",
"SINAASAPPELOLIE",
"SWEET ORANGE FLAVOUR (RI)"
],
"substances": [
"RIZATRIPTANBENZOAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h101957.pdf",
"authorised_at": "2009/09/16",
"procedure_number": "DE/H/1437/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "101957",
"additional_monitoring": "N"
}See everything about rizatriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.